New patent for Azurity drug XATMEP

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for XATMEP
Annual Drug Patent Expirations for XATMEP

Xatmep is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.

This drug has three patent family members in three countries.

The generic ingredient in XATMEP is methotrexate sodium. One supplier is listed for this compound. Additional details are available on the methotrexate sodium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at

Leave a Reply

DrugPatentWatch - Make Better Decisions
Scroll to Top